Almirall
| Almirall SA
|
|
|---|---|
 |
|
| legal form | Public company (Spain) |
| ISIN | ES0157097017 |
| founding | 1943 |
| Seat |
Barcelona , Spain
|
| management | Jorge Gallardo Ballart (Chairman of the Board of Directors) Peter Guenter (CEO) |
| Number of employees | 1,773 |
| sales | 855 million euros (2019) |
| Branch | Pharma |
| Website | www.almirall.com |
| As of December 31, 2015 | |
Almirall SA , based in Barcelona, is a listed Spanish pharmaceutical company .
overview
The product portfolio of the company, founded in 1943, focuses on drugs for the treatment of diseases of the respiratory tract, gastrointestinal tract and skin, as well as autoimmune diseases . Almirall has a direct presence in 12 countries and markets in 70 countries.
With the takeover of the Reinbek- based company Hermal in 2007, Almirall acquired its established dermatological brands - for example Aknemycin ( acne ), Balneum Hermal (dry skin), Optiderm (dry, itchy skin), Jacutin ( lice ), Tannosynt (inflammatory skin diseases) . According to its own information, Almirall is the market leader in Germany in the area of prescription drugs for dermatology .
The listed company is controlled by the Gallardo family, who, with Jorge Gallardo Ballart, also provide the chairman of the board of directors, to around 66%.
Individual evidence
- ↑ Board of Directors , accessed on March 29, 2020 (English)
- ↑ a b Annual financial statements 2019 , accessed on July 3, 2020, pdf (English)
- ^ Website of Almirall Hermal
- ↑ The Pharma Letter: Gallardo family expand ownership of Almirall , May 23, 2018, accessed March 29, 2020